ShareValue scores for PEHA.JK: Valuation 66, Quality 56, Growth 35, Health 34.

Phapros Tbk PT logo

PEHA.JK
IDX

Phapros Tbk PT

IDR 256.00(-6.57%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

3% to 16%
Valuation
66
Fair Value
Price vs Value
Quality
56
Moderate
Business Strength
Growth
35
Weak
Revenue & Earnings
Health
34
Stressed
Financial Stability
Momentum
22
Bearish
Price Trend

Company Details

About

PT Phapros Tbk, together with its subsidiaries, operates in the pharmaceutical industry in Indonesia. The company operates through Ethical; Over the Counter (OTC) Drugs; Generic Drugs Bearing (OCB); and Toll-in segments. It offers OTC drugs, including Antimo Anak, Antimo tablet, Livron B Plex, Becefort Sirop and tablet, Noza, Febrinex, Betafort suspensi, and Hemorogard. The company also provides ethical generic and branded products; and medical devices, as well as toll manufacturing. It also exports its products. The company was founded in 1954 and is headquartered in Jakarta Selatan, Indonesia. PT Phapros Tbk is a subsidiary of PT Kimia Farma Tbk.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026